To test the potential of hepcidin to treat iron disorders, we performed a simple model of iron overload (to serve as a baseline for comparison), as well as a model of iron overload followed by administration of either hamp1 or hamp2 (despite earlier results suggesting a limited involvement of hamp2 in iron metabolism). Here, HAMP is linked to iron metabolism disease.